相关实验视频
Updated: Sep 10, 2025

15:49
Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
Published on: June 9, 2022
1.5K
福斯特姆萨维尔类似物BMS-818251增强了病毒中和能力和类似的脱离突变特征
Yen-Ting Lai1,2, Adam S Dingens3,4, Megan DeMouth1
1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Antimicrobial agents and chemotherapy
|August 27, 2025
概括
与 fostemsavir 相比,BMS-818251是一种新型的HIV-1附着抑制剂,显示出优异的病毒抑制作用. 它有效地向抗药性HIV-1菌株,表明它可能导致多药性感染.
科学领域:
- 病毒学
- 药物发现
- 免疫学
背景情况:
- 艾滋病毒-1附着抑制剂对于病毒抑制至关重要.
- 福斯特姆萨维尔是一种已知的附着抑制剂,但可能会出现耐药性.
- 需要下一代抑制剂来克服耐药性并提高疗效.
研究的目的:
- 评估BMS-818251的疗效和耐药性概况.
- 为了比较BMS-818251的病毒抑制与temsvir (活性 fostemsavir).
- 识别和描述对BMS-818251的耐药性突变.
主要方法:
- 使用HIV+供体样本进行ex vivo病毒外生长测定.
- 深度突变扫描和伪型病毒中和试验.
- 异热定位热量测量和体外Env测序
主要成果:
- 与泰姆萨维尔相比,BMS-818251的病毒抑制能力更强.
- 主要在BMS-818251结合部位周围发现了耐药性突变,降低了药物亲和力.
- BMS-818251甚至对具有先前抗药性突变的HIV-1也表现出强大的活性.
结论:
- BMS-818251表现出增强的功效和可控的耐药性.
- 深度突变扫描有效预测体内耐药性.
- BMS-818251是治疗多药耐药性HIV-1的一个有希望的候选药物.
更多相关视频
相关概念视频
Subviral Agents
111
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
111
Retroviruses
12.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K
Viral Mutations
32.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.8K

